Attorneys General Urge Senate to Support Veterans by Passing the Veteran Treatment Court Coordination Act

We urge the Senate to further support this important court program. H.R. 886 would establish a Veteran Treatment Court Program in the Department of Justice to provide grants and technical assistance to state, local and tribal courts that implement Veterans Treatment Courts. As Attorneys General, we strongly support this important program in our courts and encourage the continued support of the Congress for our nation’s veterans.

Read More →

NAAG Endorses Autism CARES Act of 2019

ASD impacts hundreds of thousands of Americans. Congress began addressing autism in 2000 with the first enactment of the bill. The 161 cosponsors of the current House and Senate bills and the 118+ bipartisan members of the Congressional Coalition for Autism Research and Education demonstrate its significance. The Autism CARES Act of 2019 will continue Congress’ ongoing mission to ensure that those living with ASD receive the necessary support and research. Therefore, we, the undersigned attorneys general, ask you to support and to enact the Autism Cares Act of 2019 before September 30, 2019.

Read More →

AGs Submit Comments to FTC for Hearings on Competition and Consumer Protection in the 21st Century

Forty-three state and territory attorneys general submitted comments to the Federal Trade Commission (FTC) Hearings on Competition and Consumer Protection in the 21st Century.

Read More →

NAAG Endorses the FIGHT Act

This legislation is crucial to federal and state efforts to curb the opioid epidemic nationally and within each individual state. It is for these reasons that we commend Senators Portman and Manchin for their leadership in bringing forward this important legislation, and we urge you to take up and pass S. 2701 before the DEA’s temporary order expires.

Read More →

NAAG Requests Removal of Federal Barriers to Treat Opioid Use Disorder

Unfortunately, there are three significant barriers to treating opioid use disorder that we cannot change at the state level and that must be tackled at the federal level. We share these barriers below in the hope that we can work together to remove them and allow more providers to offer treatment for opioid use disorder and other substance use disorders.

Read More →

NAAG Urges FDA to Include AGs in Oversight of Cannabis-Derived Products

As the primary enforcers of our respective states’ consumer protection laws, we offer a unique perspective as to the new legalized market of certain cannabis and cannabis-derived compounds, including CBD products. We write to express our hope that the FDA continues to explore manufacturing, testing, and marketing best practices so that consumers are not at risk of misleading advertising or harm to their health from dangerous additives or undisclosed risks of use. Although products containing cannabis or cannabis-derived compounds may well offer real benefits to consumers, it is important that consumers have reliable risk and benefit information to make informed choices about initiating and continuing the use of these products. A crucial element of FDA regulation and oversight should be an on-going assessment of the potential risks or benefits of these products, particularly for specific populations such as pregnant women, adolescents and children, and the elderly. How these products interact with other dietary or pharmaceutical products should be included in this assessment. It is also important that companies not mislead consumers. Scientific and medical data from the FDA would assist in meaningful enforcement of advertising laws and regulations by the states.

Read More →

AGs Send Policy Guidelines to Streaming Industry to Combat Youth Tobacco Use

Given the recent significant rise in tobacco use by young people, particularly the use of e-cigarettes, preventing initiation and use of tobacco products is of critical importance to us and the public health community, and we sincerely hope it will be addressed by the streaming industry.

Read More →

National Association of Attorneys General Announces Annual Award Recipients

Washington, D.C. — The National Association of Attorneys Generals (NAAG) announced its annual award winners at the President’s Dinner hosted during the Capital Forum on Dec. 10. Kansas Attorney General Derek Schmidt was the recipient of the Kelley-Wyman Award, the Association’s most prestigious honor given annually to the attorney general who has done the most to achieve…

Read More →

All 56 State and Territory Attorneys General Ask Congress to Permanently Classify Fentanyl-Related Substances as Schedule I Drugs

Washington, D.C. — The National Association of Attorneys General (NAAG) sent a letter to Senate leadership, urging Congress to permanently classify fentanyl-related substances as Schedule I drugs. Schedule I drugs are defined as drugs with no currently accepted medical use and a high potential for abuse. All 56 state and territory attorneys general signed the letter asking Congress to…

Read More →

Montana Attorney General Tim Fox is Elected NAAG President

Washington, D.C. — Montana Attorney General Tim Fox was elected president of the National Association of Attorneys General (NAAG) during its Capital Forum, Dec. 9-11. Attorney General Fox has selected “Transformational Leadership and Civility” as his presidential initiative. “I am humbled beyond words that my fellow state, territorial, and District of Columbia attorneys general have chosen…

Read More →